The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Senescence, Necrosis, and Apoptosis Govern Circulating Cell-free DNA Release Kinetics
Open accessAbstract
The kinetics of circulating cell-free DNA (cfDNA) release may provide a real-time assessment of induced cell death. However, there is a limited understanding of the underlying biological rationale for cfDNA release following distinct treatments and cell death mechanisms. Here, we uncover a complex interplay between apoptosis, necrosis, and senescence in determining cfDNA release kinetics. Utilizing multiple in vitro and in vivo preclinical models, we show how cfDNA release is modulated through a combination of apoptotic and senescent triggers and inhibitors. Interestingly, we identify treatment-induced senescence as a previously unrecognized determinant of cfDNA kinetics that can counteract its release. Necrosis is the predominant cell death mechanism that consistently contributes to cfDNA release in response to ionizing radiation, and, surprisingly, apoptosis plays a comparatively minor role in some tumors. Based on our results, we propose a model to explain cfDNA release from cells over time, with important implications for future studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Liquid biopsies come of age: Towards implementation of circulating tumour DNA
Wan, J. C. M., Massie, C., Garcia-Corbacho, J., Mouliere, F., Brenton, J. D., Caldas, C., Pacey, S., Baird, R., & Rosenfeld, N. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.7 · Cited by 2,809
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Newman, A. M., Bratman, S. V., To, J., Wynne, J. F., Eclov, N. C. W., Modlin, L. A., Liu, C. L., Neal, J. W., Wakelee, H. A., Merritt, R. E., et al. (2014) · Nature Medicine · doi:10.1038/nm.3519 · Cited by 2,220
Self-citationLiquid Biopsies: Genotyping Circulating Tumor DNA
Diaz, L. A., & Bardelli, A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2011 · Cited by 2,210
Senescent cells: an emerging target for diseases of ageing
Childs, B. G., Gluscevic, M., Baker, D. J., Laberge, R.-M., Marquess, D., Dananberg, J., & van Deursen, J. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.116 · Cited by 1,284
Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL
Yosef, R., Pilpel, N., Tokarsky-Amiel, R., Biran, A., Ovadya, Y., Cohen, S., Vadai, E., Dassa, L., Shahar, E., Condiotti, R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11190 · Cited by 1,032
Therapy-induced senescence in cancer.
Ewald, J. A., Desotelle, J. A., Wilding, G., & Jarrard, D. F. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq364 · Cited by 824
Origins, structures, and functions of circulating DNA in oncology
Thierry, A. R., El Messaoudi, S., Gahan, P. B., Anker, P., & Stroun, M. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9629-x · Cited by 818
Granule exocytosis mediates immune surveillance of senescent cells
Sagiv, A., Biran, A., Yon, M., Simon, J., Lowe, S. W., & Krizhanovsky, V (2013) · Oncogene · doi:10.1038/onc.2012.206 · Cited by 240
Research works printed but not linked: 38
- Abbosh, 2017, Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution, Nature, 545, 446, 10.1038/nature22364 · DOI · Paper page
- Arenz, 2014, Increased radiosensitivity of HPV-positive head and neck cancer cell lines due to cell cycle dysregulation and induction of apoptosis, Strahlenther. Onkol., 190, 839, 10.1007/s00066-014-0605-5 · DOI
- Banys, 2012, Dormancy in breast cancer, Breast Cancer (Dove Med. Press), 4, 183
- Bettegowda, 2014, Detection of circulating tumor DNA in early- and late-stage human malignancies, Sci.Transl. Med., 6, 224ra24, 10.1126/scitranslmed.3007094 · DOI · Paper page
- Blitzer, 2014, Review of the clinical and biologic aspects of human papillomavirus-positive squamous cell carcinomas of the head and neck, Int. J. Radiat. Oncol. Biol. Phys., 88, 761, 10.1016/j.ijrobp.2013.08.029 · DOI
- Cao, 2012, Quantitation of human papillomavirus DNA in plasma of oropharyngeal carcinoma patients, Int. J. Radiat. Oncol. Biol. Phys., 82, e351, 10.1016/j.ijrobp.2011.05.061 · doi:10.1016/j.ijrobp.2011.05.061
- Desai, 2006, Novel kinase inhibitors in renal cell carcinoma: progressive development of static agents, Curr. Urol. Rep., 7, 16, 10.1007/s11934-006-0033-x · DOI
- Diehl, 2008, Circulating mutant DNA to assess tumor dynamics, Nat. Med., 14, 985, 10.1038/nm.1789 · DOI · Paper page
- Husain, 2017, Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine, Clin. Cancer Res., 23, 4716, 10.1158/1078-0432.CCR-17-0454 · DOI
- Jahr, 2001, DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells, Cancer Res., 61, 1659
- Jiang, 2016, The Long and Short of Circulating Cell-Free DNA and the Ins and Outs of Molecular Diagnostics, Trends Genet., 32, 360, 10.1016/j.tig.2016.03.009 · DOI · Paper page
- Jiang, 2015, Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients, Proc. Natl. Acad. Sci. USA, 112, E1317, 10.1073/pnas.1500076112 · DOI · Paper page
- Kamat, 2006, Circulating cell-free DNA: a novel biomarker for response to therapy in ovarian carcinoma, Cancer Biol. Ther., 5, 1369, 10.4161/cbt.5.10.3240 · DOI
- Kimple, 2013, Enhanced radiation sensitivity in HPV-positive head and neck cancer, Cancer Res., 73, 4791, 10.1158/0008-5472.CAN-13-0587 · DOI · Paper page
- Lo, 1999, Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma, Cancer Res., 59, 1188
- Lo, 2000, Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma, Cancer Res., 60, 2351
- Lo, 2010, Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus, Sci. Transl. Med., 2, 61ra91, 10.1126/scitranslmed.3001720 · DOI · Paper page
- Maier, 2016, Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization, Int. J. Mol. Sci., 17, E102, 10.3390/ijms17010102 · DOI · Paper page
- Mair, 2018, Measurement of Plasma Cell-Free Mitochondrial Tumor DNA Improves Detection of Glioblastoma in Patient-Derived Orthotopic Xenograft Models, Cancer Res., 79, 220, 10.1158/0008-5472.CAN-18-0074 · DOI
- Mandel, 1948, Les acides nucléiques du plasma sanguin chez l’homme, C. R. Seances Soc. Biol. Fil., 142, 241
- Martin, 2006, Novel non-cytotoxic therapy in ovarian cancer: current status and future prospects, J. Natl. Compr. Canc. Netw., 4, 955, 10.6004/jnccn.2006.0079 · DOI
- Mouliere, 2011, High fragmentation characterizes tumour-derived circulating DNA, PLoS One, 6, e23418, 10.1371/journal.pone.0023418 · DOI · Paper page
- Mouliere, 2018, Enhanced detection of circulating tumor DNA by fragment size analysis, Sci. Transl. Med., 10, eaat4921, 10.1126/scitranslmed.aat4921 · DOI · Paper page
- Muhanna, 2017, Cell-Free DNA Kinetics in a Pre-Clinical Model of Head and Neck Cancer, Sci. Rep., 7, 16723, 10.1038/s41598-017-17079-6 · DOI
- Nelyudova, 2007, By blocking apoptosis, Bcl-2 in p38-dependent manner promotes cell cycle arrest and accelerated senescence after DNA damage and serum withdrawal, Cell Cycle, 6, 2171, 10.4161/cc.6.17.4610 · DOI
- Rago, 2007, Serial assessment of human tumor burdens in mice by the analysis of circulating DNA, Cancer Res., 67, 9364, 10.1158/0008-5472.CAN-07-0605 · DOI · Paper page
- Schmitt, 2002, A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy, Cell, 109, 335, 10.1016/S0092-8674(02)00734-1 · DOI · Paper page
- Schneider, 2017, Lack of differences in radiation-induced immunogenicity parameters between HPV-positive and HPV-negative human HNSCC cell lines, Radiother. Oncol., 124, 411, 10.1016/j.radonc.2017.08.018 · DOI
- Schwarzenbach, 2011, Cell-free nucleic acids as biomarkers in cancer patients, Nat. Rev. Cancer, 11, 426, 10.1038/nrc3066 · DOI · Paper page
- Serpas, 2019, Dnase1l3 deletion causes aberrations in length and end-motif frequencies in plasma DNA, Proc. Natl. Acad. Sci. USA, 116, 641, 10.1073/pnas.1815031116 · DOI · Paper page
- Thierry, 2010, Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts, Nucleic Acids Res., 38, 6159, 10.1093/nar/gkq421 · DOI · Paper page
- To, 2003, Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma, Clin. Cancer Res., 9, 3254
- Vermeer, 2013, Radiation-induced loss of cell surface CD47 enhances immune-mediated clearance of human papillomavirus-positive cancer, Int. J. Cancer, 133, 120, 10.1002/ijc.28015 · DOI
- Vu, 2010, HPV-induced oropharyngeal cancer, immune response and response to therapy, Cancer Lett., 288, 149, 10.1016/j.canlet.2009.06.026 · DOI
- Wang, 2017, Characterization of the release and biological significance of cell-free DNA from breast cancer cell lines, Oncotarget, 8, 43180, 10.18632/oncotarget.17858 · DOI
- Winquist, 2006, Non-hormonal systemic therapy in men with hormone-refractory prostate cancer and metastases: a systematic review from the Cancer Care Ontario Program in Evidence-based Care’s Genitourinary Cancer Disease Site Group, BMC Cancer, 6, 112, 10.1186/1471-2407-6-112 · DOI
- Xi, 2016, Circulating Tumor DNA as an Early Indicator of Response to T-cell Transfer Immunotherapy in Metastatic Melanoma, Clin. Cancer Res., 22, 5480, 10.1158/1078-0432.CCR-16-0613 · DOI
- Yao, 2016, Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: A qualitative study, Gene, 590, 142, 10.1016/j.gene.2016.06.033 · DOI · Paper page
Cited by
A guide to assessing cellular senescence in vitro and in vivo
González‐Gualda, E., Baker, A. G., Fruk, L., & Muñoz‐Espín, D. (2021) · The FEBS Journal · doi:10.1111/febs.15570 · Cited by 645
Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies
Lo, Y. M. D., Han, D. S. C., Jiang, P., & Chiu, R. W. K. (2021) · Science · doi:10.1126/science.aaw3616 · Cited by 662
Release mechanisms of major DAMPs
Murao, A., Aziz, M., Wang, H., Brenner, M., & Wang, P. (2021) · Apoptosis · doi:10.1007/s10495-021-01663-3 · Cited by 582
Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual Disease
Moding, E. J., Nabet, B. Y., Alizadeh, A. A., & Diehn, M. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0634 · Cited by 325
Kasravi, M., Ahmadi, A., Babajani, A., Mazloomnejad, R., Hatamnejad, M. R., Shariatzadeh, S., Bahrami, S., & Niknejad, H. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00348-z · Cited by 316
Metadata
- Authors
- Rostami, A., Lambie, M., Yu, C. W., Stambolic, V., Waldron, J. N., & Bratman, S. V.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 31
- Issue
- 13
- Pages
- 107830
- ISSN
- 2211-1247 (ISSN-L)
- OpenAlex
- W3038278491
- Cited by
- 202
- References
- 9
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 8 d)
- Funders
- Cancer Research Society (21282)
- Princess Margaret Cancer Foundation
- Government of Ontario
- Canadian Cancer Society Research Institute (704762)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Senescence, Necrosis, and Apoptosis Govern Circulating Cell-free DNA Release Kinetics. https://app.cochat.ai/papers/10.1016/j.celrep.2020.107830
- The paper
- Rostami, A., Lambie, M., Yu, C. W., Stambolic, V., Waldron, J. N., & Bratman, S. V. (2020). Senescence, Necrosis, and Apoptosis Govern Circulating Cell-free DNA Release Kinetics. Cell Reports. https://doi.org/10.1016/j.celrep.2020.107830
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.